02815nam a2200313 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002600112020002700138040002100165035002100186050002200207082002100229100003000250245014700280260004800427300002500475504005100500505158800551533015202139650002102291655002902312710001702341856012602358999001702484ebr10580148CaPaEBRm        u        cr cn|||||||||120117s2012    njua    sb    001 0 eng d  z  2012002022  z9781118149652 (cloth)  z9781118347836 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)80834637714aRB56b.D37 2012eb04a615.7/0407242231 aDasgupta, Amitava,d1958-10aResolving erroneous reports in toxicology and therapeutic drug monitoringh[electronic resource] :ba comprehensive guide /cAmitava Dasgupta.  aHoboken, N.J. :bJohn Wiley & Sons,cc2012.  aviii, 457 p. :bill.  aIncludes bibliographical references and index.0 aAn introduction to tests performed in toxicology laboratories and methodologies available for such testings -- Challenges in drugs of abuse testing -- False positive results in immunoassays for drugs of abuse testing -- True positive drugs of abuse test results due to prescription and non-prescription drugs -- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs -- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests -- False positive alcohol tests using breath analyzers and automated analyzers -- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol -- Poisoning with warfarin and superwarfarin : what laboratory can do? -- Plant poisoning and clinical laboratory -- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody -- Interferences in immunoassays used for digoxin monitoring -- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients -- Interferences in immunoassays used for monitoring tricyclic antidepressant -- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods -- Effect of drug-herb interactions on therapeutic drug monitoring -- Pharmacogenomics and toxicology laboratory -- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aDrug monitoring. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10580148zAn electronic book accessible through the World Wide Web; click to view  c85284d85284